Anteris (TAVR) Advisory Board member Dr Jeffrey Popma
Posted on 20 May 2020 in Cardiovascular News
Medtronic has that announced Jeffrey J Popma (Harvard Medical School; Beth Israel Deaconess Medical Center, Boston, USA) will join the company as vice president and chief medical officer supporting the coronary, renal denervation, and structural heart businesses. A press release reports that Popma will serve as a strategic adviser for cardiovascular device innovation, and assist in the development of an expanding clinical research portfolio, leveraging his deep expertise in interventional cardiology and transcatheter-based therapies.
https://cardiovascularnews.com/jeffrey-j-popma-joins-medtronic-as-vice-president-and-chief-medical-officer-for-coronary-renal-denervation-and-structural-heart-businesses/
- Forums
- ASX - By Stock
- Cardiovascular News
Anteris (TAVR) Advisory Board member Dr Jeffrey PopmaPosted on...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $342.3M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.70 | $55.56K | 3.098K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 100 | $17.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.91 | 60 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 108 | 17.730 |
1 | 26 | 17.710 |
1 | 220 | 17.700 |
2 | 226 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.920 | 47 | 3 |
17.990 | 59 | 2 |
18.000 | 67 | 2 |
18.030 | 27 | 1 |
18.100 | 700 | 1 |
Last trade - 15.45pm 12/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |